Modern rheumatology · 2026
Joint involvement patterns and patient-reported satisfaction in difficult-to-treat rheumatoid arthritis: results from the multicentre observational cohort, FRANK Registry.
СтатьяМногоцентровое исследованиеНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Arisumi Shinkichi, Fujiwara Toshifumi, Tsushima Hidetoshi, Kondo Masakazu, Yamada Hisakata, Suematsu Eiichi, Miyamura Tomoya, Ishida Motoko, Nakamura Masataka, Fukushi Jun-Ichi, Sakuraba Koji, Inoue Yasushi, Tsuru Tomomi, Shuto Toshihide, Yoshizawa Seiji, Ohishi Masanobu, Kamo Kenta, Maeyama Akira, Ayano Masahiro, Niiro Hiroaki, Hara Daisuke, Yamaguchi Ryosuke, Akasaki Yukio, Tsurui Ryosuke, Yasumoto Keitaro, Natori Takahiro, Sugita Toshiaki, Nakashima Yasuharu
Аннотация
OBJECTIVE: This study aimed to characterize patterns of joint involvement and clinical features in patients with difficult-to-treat rheumatoid arthritis (D2T RA).
METHODS: A cross-sectional analysis was conducted using the FRANK Registry, a multicentre cohort (n = 3770). D2T RA was defined based on the 2021 European Alliance of Associations for Rheumatology criteria. Propensity score matching by age and disease duration was applied to compare D2T RA patients with matched non-D2T RA. Joint involvement was assessed using 28-joint counts and Paired Joint Pathology Scores. Patient satisfaction was evaluated across four domains: treatment efficacy, cost, activities of daily living, and global treatment.
RESULTS: Among 3770 patients, 108 (2.9%) fulfilled the criteria for D2T RA. Compared with matched controls, D2T RA patients had significantly higher anti-cyclic citrullinated peptide antibody titres, more frequent use of targeted synthetic disease-modifying antirheumatic drugs, and a higher prevalence of herpes zoster and methotrexate-associated lymphoproliferative disorder. Joint-level analysis revealed significantly greater involvement of the acromioclavicular, elbow, wrist, second finger proximal interphalangeal, and knee joints. Patient satisfaction scores were significantly lower in D2T RA, particularly regarding treatment cost and daily functioning.
CONCLUSIONS: D2T RA is associated with distinctive joint involvement, as well as reduced patient satisfaction. A joint-focused and patient-centred management approach is essential to improve outcomes in this challenging RA subset.
METHODS: A cross-sectional analysis was conducted using the FRANK Registry, a multicentre cohort (n = 3770). D2T RA was defined based on the 2021 European Alliance of Associations for Rheumatology criteria. Propensity score matching by age and disease duration was applied to compare D2T RA patients with matched non-D2T RA. Joint involvement was assessed using 28-joint counts and Paired Joint Pathology Scores. Patient satisfaction was evaluated across four domains: treatment efficacy, cost, activities of daily living, and global treatment.
RESULTS: Among 3770 patients, 108 (2.9%) fulfilled the criteria for D2T RA. Compared with matched controls, D2T RA patients had significantly higher anti-cyclic citrullinated peptide antibody titres, more frequent use of targeted synthetic disease-modifying antirheumatic drugs, and a higher prevalence of herpes zoster and methotrexate-associated lymphoproliferative disorder. Joint-level analysis revealed significantly greater involvement of the acromioclavicular, elbow, wrist, second finger proximal interphalangeal, and knee joints. Patient satisfaction scores were significantly lower in D2T RA, particularly regarding treatment cost and daily functioning.
CONCLUSIONS: D2T RA is associated with distinctive joint involvement, as well as reduced patient satisfaction. A joint-focused and patient-centred management approach is essential to improve outcomes in this challenging RA subset.